| |
|
|
|
Aptevo Therapeutics Inc  
|
|
7.64 -0.23 (-0.03%) |
08-12 13:22 |
|
Open: |
8.01 |
Pre close: |
7.87 |
Target:
|
9.91 
|
|
High: |
8.02 |
Low: |
7.46 |
Resistance:
|
8.48
9.44
|
|
Volume: |
57,281 |
Market Cap: |
25M |
Support:
|
6.93
5.77
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.08
|
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
8.20  |
Signal(12,26,9): |
0.21 |
|
MA(100): |
6.16 |
Stochastic Oscillator |
%K(14,3):
|
17.40 |
|
MA(250): |
7.39 |
%D(3): |
29.28 |
|
Average Volume(K) |
3-Month: |
66078
|
52-Week |
High:
|
12.04 |
|
10-Days: |
10187 |
Low: |
2.94 |
|
RSI |
RSI(14):
|
45.07 |
Change(%): |
-26.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-7.640 |
Return on Equity (ttm) |
-158.3 |
Shares Out. (M) |
3.23 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-46.0 |
Shares Float (M) |
2.41 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.08 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
44.11 |
|
Forward EPS |
-0.990 |
Gross Profit (p.s.) |
-5.344 |
Shares Short (K) |
194 |
|
Book Value (p.s.) |
4.690 |
EBITDA (p.s.) |
-11.440 |
P/E |
-1.00 |
|
Sales Per Share |
10.037 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.63 |
|
Profit Margin |
-78.75 |
Operating Cash Flow
(M) |
-39.71 |
P/S |
0.76 |
|
Operating Margin |
-120.45 |
Levered Free Cash Flow
(M) |
-13.63 |
P/CF |
-0.62 |
|
|
|
|
|
|
